BR9507437A - Base livre de halofantrina e composições para o tratamento da malária - Google Patents
Base livre de halofantrina e composições para o tratamento da maláriaInfo
- Publication number
- BR9507437A BR9507437A BR9507437A BR9507437A BR9507437A BR 9507437 A BR9507437 A BR 9507437A BR 9507437 A BR9507437 A BR 9507437A BR 9507437 A BR9507437 A BR 9507437A BR 9507437 A BR9507437 A BR 9507437A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- free base
- halofantrine
- malaria
- compositions
- Prior art date
Links
- 239000012458 free base Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 201000004792 malaria Diseases 0.000 title 1
- FOHHNHSLJDZUGQ-VWLOTQADSA-N Halofantrine Chemical compound FC(F)(F)C1=CC=C2C([C@@H](O)CCN(CCCC)CCCC)=CC3=C(Cl)C=C(Cl)C=C3C2=C1 FOHHNHSLJDZUGQ-VWLOTQADSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 229960003242 halofantrine Drugs 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9406858A GB9406858D0 (en) | 1994-04-07 | 1994-04-07 | New use and formulations |
| GB9416404A GB9416404D0 (en) | 1994-08-13 | 1994-08-13 | New use and formulations |
| PCT/EP1995/001257 WO1995027492A1 (en) | 1994-04-07 | 1995-04-04 | Halofantrine free base for the treatment of malaria and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9507437A true BR9507437A (pt) | 1997-09-16 |
Family
ID=26304653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9507437A BR9507437A (pt) | 1994-04-07 | 1995-04-04 | Base livre de halofantrina e composições para o tratamento da malária |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5968987A (pt) |
| EP (1) | EP0754045B1 (pt) |
| JP (1) | JPH09512794A (pt) |
| CN (1) | CN1145030A (pt) |
| AT (1) | ATE213937T1 (pt) |
| AU (1) | AU685263B2 (pt) |
| BR (1) | BR9507437A (pt) |
| CA (1) | CA2187185A1 (pt) |
| CZ (1) | CZ293696A3 (pt) |
| DE (1) | DE69525740T2 (pt) |
| ES (1) | ES2170143T3 (pt) |
| HU (1) | HUT76051A (pt) |
| NO (1) | NO964238D0 (pt) |
| NZ (1) | NZ284068A (pt) |
| PL (1) | PL179608B1 (pt) |
| WO (1) | WO1995027492A1 (pt) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5340298A (en) * | 1996-12-27 | 1998-07-31 | Takeda Chemical Industries Ltd. | Stabilized tricyclic compound |
| US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
| IN191696B (pt) * | 1999-02-12 | 2003-12-20 | Council Scient Ind Res | |
| US6616942B1 (en) * | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
| US6759058B1 (en) * | 2001-04-25 | 2004-07-06 | Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences | Enteric-coated proliposomal formulations for poorly water soluble drugs |
| AUPR573001A0 (en) * | 2001-06-15 | 2001-07-12 | Glaxo Wellcome Australia Ltd | Lymphatic drug delivery system |
| AU2002343555A1 (en) | 2001-11-14 | 2003-05-26 | Texas Tech University | Eutectic-based self-nanoemulsified drug delivery system |
| US20060148776A1 (en) * | 2003-03-13 | 2006-07-06 | Conforma Therapeutics Corporation | Drug formulations having long and medium chain triglycerides |
| AU2004277951B2 (en) | 2003-09-29 | 2010-11-11 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
| US20050220866A1 (en) * | 2004-04-02 | 2005-10-06 | Dr. Reddy's Laboratories Limited | Novel capsule formulations of etoposide for oral use |
| US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
| SA109300195B1 (ar) | 2008-03-28 | 2013-04-20 | Astrazeneca Ab | تركيبة صيدلانية جديدة مضادة للسرطان |
| CA2690490C (en) * | 2010-01-19 | 2012-06-26 | Accucaps Industries Limited | Pharmaceutical formulations of loratadine for encapsulation and combinations thereof |
| US9309136B2 (en) * | 2014-06-12 | 2016-04-12 | Tersus Environmental, Llc | Bioremediation of soil and groundwater |
| WO2015193380A2 (en) * | 2014-06-19 | 2015-12-23 | Solural Pharma ApS | Solid oral dosage form of lipophilic compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4818767A (en) * | 1983-11-02 | 1989-04-04 | Smithkline Beckman Corporation | Quinate salts of antimalarial phenanthrenemethanol compounds |
| US4507288A (en) * | 1983-09-16 | 1985-03-26 | Smithkline Beckman Corporation | β-Glycerophosphate salts of antimalarial phenanthrenemethanol compounds |
| US5278173A (en) * | 1988-06-30 | 1994-01-11 | Davis Michael H | Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo |
| MX9204103A (es) * | 1991-07-15 | 1993-02-01 | Smithkline Beecham Plc | Halogenofantrina, sus sales y composiciones que las contienen. |
-
1995
- 1995-04-04 PL PL95316656A patent/PL179608B1/pl unknown
- 1995-04-04 WO PCT/EP1995/001257 patent/WO1995027492A1/en not_active Ceased
- 1995-04-04 AU AU22568/95A patent/AU685263B2/en not_active Ceased
- 1995-04-04 ES ES95915852T patent/ES2170143T3/es not_active Expired - Lifetime
- 1995-04-04 EP EP95915852A patent/EP0754045B1/en not_active Expired - Lifetime
- 1995-04-04 JP JP7526060A patent/JPH09512794A/ja active Pending
- 1995-04-04 CZ CZ962936A patent/CZ293696A3/cs unknown
- 1995-04-04 HU HU9602740A patent/HUT76051A/hu unknown
- 1995-04-04 DE DE69525740T patent/DE69525740T2/de not_active Expired - Fee Related
- 1995-04-04 AT AT95915852T patent/ATE213937T1/de not_active IP Right Cessation
- 1995-04-04 NZ NZ284068A patent/NZ284068A/en unknown
- 1995-04-04 CA CA002187185A patent/CA2187185A1/en not_active Abandoned
- 1995-04-04 BR BR9507437A patent/BR9507437A/pt not_active Application Discontinuation
- 1995-04-04 CN CN95192440A patent/CN1145030A/zh active Pending
-
1996
- 1996-10-04 NO NO964238A patent/NO964238D0/no not_active Application Discontinuation
-
1997
- 1997-10-15 US US08/950,459 patent/US5968987A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| NO964238L (no) | 1996-10-04 |
| NO964238D0 (no) | 1996-10-04 |
| ATE213937T1 (de) | 2002-03-15 |
| WO1995027492A1 (en) | 1995-10-19 |
| JPH09512794A (ja) | 1997-12-22 |
| EP0754045A1 (en) | 1997-01-22 |
| ES2170143T3 (es) | 2002-08-01 |
| PL316656A1 (en) | 1997-02-03 |
| EP0754045B1 (en) | 2002-03-06 |
| CA2187185A1 (en) | 1995-10-19 |
| HU9602740D0 (en) | 1996-11-28 |
| AU2256895A (en) | 1995-10-30 |
| NZ284068A (en) | 1998-06-26 |
| DE69525740D1 (de) | 2002-04-11 |
| DE69525740T2 (de) | 2002-10-24 |
| US5968987A (en) | 1999-10-19 |
| CN1145030A (zh) | 1997-03-12 |
| PL179608B1 (pl) | 2000-10-31 |
| AU685263B2 (en) | 1998-01-15 |
| HUT76051A (en) | 1997-06-30 |
| MX9604611A (es) | 1997-11-29 |
| CZ293696A3 (en) | 1997-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9507437A (pt) | Base livre de halofantrina e composições para o tratamento da malária | |
| BR0112962A (pt) | Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet | |
| DK0760848T3 (da) | Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf | |
| BRPI0113286B8 (pt) | pirazóis substituídos e composição farmacêutica compreendendo os mesmos. | |
| BR9908020A (pt) | Fórmula para polimento ótico | |
| FR2766176B1 (fr) | Compositions a base de derives de resveratrol | |
| BR0211390A (pt) | Tratamento de infecções da unha com no | |
| SE9802729D0 (sv) | Novel Compounds | |
| BR9900320A (pt) | Composição antimicrobiana | |
| ES2193337T3 (es) | Utilizacion de sales de estroncio para el tratamiento de la artrosis. | |
| ATE273690T1 (de) | Zusammensetzung zur hautdesinfizierung | |
| DK1097173T3 (da) | Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler | |
| BR9811099A (pt) | Inibidores de urocinase | |
| RU95106674A (ru) | Полиеновые соединения, фармацевтическая и косметическая композиция на их основе | |
| PT1228028E (pt) | Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular | |
| BR0315437A (pt) | Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos | |
| CY1105482T1 (el) | Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων | |
| BR9611727A (pt) | Derivados de quínolina anti-malária | |
| BR9907655A (pt) | Derivados de ácido di-hidróxi-hexanóico | |
| PT1107793E (pt) | Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados | |
| NO20010940L (no) | TAN-1057 derivater | |
| BG100248A (bg) | Инхибитори на скваленсинтетаза | |
| BR9806083A (pt) | Composi-Æo farmac-utica para o tratamento da hapattite c | |
| ATE305517T1 (de) | Neurotrypsin | |
| NO20021573D0 (no) | Tverrbundne kopolymerer basert på ikke-tverrbundne polykarboksylkopolymerer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements | ||
| B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/00 (2006.01), A61K 9/107 (2006.0 |